Benedikte H.
- Country
- Denmark
- Department
- Department of Oncology
Research Overview
Data & Insights
Has run more than one trial at 15 of 56 partner sites.
Specializations
Neuro-Oncology Focus
The investigator specializes in treating glioblastoma, particularly focusing on newly diagnosed cases and their management strategies. Their expertise extends to cases involving MGMT unmethylated glioblastoma, representing a specific molecular subtype of this aggressive brain cancer.
- Primary Brain Tumors
- WHO Grade IV Gliomas
- Post-surgical Treatment Approaches
Their therapeutic interests include exploring novel treatment combinations for patients following tumor resection procedures.
Molecular Therapeutics
The investigator's work encompasses the evaluation of targeted therapies, including PARP inhibitors and novel therapeutic agents for brain cancer treatment. Their focus includes investigating alternatives to conventional chemotherapy approaches.
- Targeted Cancer Therapies
- Molecular Biomarkers
- Treatment Resistance Mechanisms
Their therapeutic approach incorporates molecular profiling to guide treatment decisions in neuro-oncology.
Post-Surgical Care
The investigator has developed expertise in managing post-resection treatment protocols for brain cancer patients. Their work includes evaluating both complete and partial tumor resection cases with innovative therapeutic strategies.
- Adjuvant Therapy Protocols
- Treatment Optimization
- Patient Monitoring Strategies
Their focus includes developing comprehensive treatment approaches for newly diagnosed cases following surgical intervention.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
